RareCyte
Life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
$120m (Public information from Jun 2024)
Seattle Washington (HQ)
Authorizing premium user...